glp-1 and dual glp-1/gip receptor agonists Potential Use of GIP/GLP-1 for Respiratory Disorders: Where Are We at? Understanding GLP-1 receptor agonists and
Description
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes and inadequate glycemic control: A randomized, double-blind, placebo-controlled study

doi: 10.1172/JCI178239

Endocrinology 133: 57-62, 1993

Diabetes Care 44 , 10201026 (2021) S.C

This psychological shift often proves more valuable than the weight loss itself for long-term success

Increased cytoplasmic Ca +2 triggers mitochondrial ATP generation and insulin exocytosis from insulin granules
